At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4007 Pharmacy
Not Yet Opened 12-22 16:00:00 EST
861.63
+5.89
+0.69%
High862.21Low852.78Vol393.78M
Open855.73D1 Closing855.73Amplitude1.10%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O14.87BT/O Rate--Tradable Shares0.00
P/B5.184615ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma
GlobeNewswire  ·  14:00
Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma
PRESS DIGEST -Wall Street Journal - December 23
Reuters  ·  13:13
PRESS DIGEST -Wall Street Journal - December 23
Assessing Oculis Holding (NasdaqGM:OCS) Valuation After FDA Backing for OCS‑05 and PIONEER Program Progress
Simply Wall St.  ·  10:16
Assessing Oculis Holding (NasdaqGM:OCS) Valuation After FDA Backing for OCS‑05 and PIONEER Program Progress
Novo Nordisk, Starfighters Space, D-Wave Quantum, Sidus Space And ZIM Integrated Shipping: Why These 5 Stocks Are On Investors' Radars Today
Benzinga_recent_news  ·  09:53
Novo Nordisk, Starfighters Space, D-Wave Quantum, Sidus Space And ZIM Integrated Shipping: Why These 5 Stocks Are On Investors' Radars Today
Rapport Therapeutics (RAPP): Valuation Check After Joining the S&P Pharmaceuticals Select Industry Index
Simply Wall St.  ·  09:18
Rapport Therapeutics (RAPP): Valuation Check After Joining the S&P Pharmaceuticals Select Industry Index
SM launches free MSME sustainability learning program
prnewswire  ·  08:32
SM launches free MSME sustainability learning program
Is JW (Cayman) Therapeutics (HKG:2126) A Risky Investment?
Simply Wall St.  ·  07:59
Is JW (Cayman) Therapeutics (HKG:2126) A Risky Investment?
Pill Version of Wegovy Is Approved for Use in the U.S. -- Update
Dow Jones  ·  07:38
Pill Version of Wegovy Is Approved for Use in the U.S. -- Update
Novo Nordisk wins US approval for weight-loss pill
Reuters  ·  06:53
Novo Nordisk wins US approval for weight-loss pill
Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
Dow Jones  ·  06:27
Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Dow Jones  ·  06:23
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Assertio to Effect 1-for-15 Reverse Stock Split
MT Newswires Live  ·  06:20
Assertio to Effect 1-for-15 Reverse Stock Split
Pliant Therapeutics Files Initial Beneficial Ownership Statement for Chief Operating Officer Minnie Kuo
Reuters  ·  06:03
Pliant Therapeutics Files Initial Beneficial Ownership Statement for Chief Operating Officer Minnie Kuo
Jupiter Neurosciences Inc. Held Annual Shareholder Meeting
Reuters  ·  05:31
Jupiter Neurosciences Inc. Held Annual Shareholder Meeting
Assertio Holdings Announces 1-for-15 Reverse Stock Split
Reuters  ·  05:30
Assertio Holdings Announces 1-for-15 Reverse Stock Split
Nektar Therapeutics (NKTR) Stock Slides Despite Analyst Optimism On Alopecia Data
Benzinga  ·  05:19
Nektar Therapeutics (NKTR) Stock Slides Despite Analyst Optimism On Alopecia Data
EVP Marshall Urist Reports Disposal of Royalty Pharma plc Common Shares
Reuters  ·  05:10
EVP Marshall Urist Reports Disposal of Royalty Pharma plc Common Shares
Cassava Sciences Names Dawn C. Bir to Compensation Committee
Reuters  ·  05:10
Cassava Sciences Names Dawn C. Bir to Compensation Committee
Supernus Pharmaceuticals SVP Frank Mottola Reports Sale of Common Shares
Reuters  ·  05:05
Supernus Pharmaceuticals SVP Frank Mottola Reports Sale of Common Shares
Emmaus Life Sciences Swaps $3M Note for New Equity and $600K Convertible Note
Reuters  ·  05:02
Emmaus Life Sciences Swaps $3M Note for New Equity and $600K Convertible Note

Introduction

Company Name.
BK4007
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--